Beneficial effects of raloxifene and atorvastatin on serum lipids.
Tsakok
A D
AD
D000924:Anticholesteremic Agents / Q000494:pharmacology*; D000069059:Atorvastatin; D015986:Confounding Factors, Epidemiologic; D006538:Heptanoic Acids / Q000494:pharmacology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008055:Lipids / Q000097:blood*; D011758:Pyrroles / Q000494:pharmacology*; D020849:Raloxifene Hydrochloride / Q000494:pharmacology*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011758:Pyrroles; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D000069059:Atorvastatin